# Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD

> **NCT02561520** · PHASE1 · WITHDRAWN · sponsor: **Ladan Espandar**

## Conditions studied

- Graft-versus-host Disease

## Interventions

- **BIOLOGICAL:** PRP eye drops
- **BIOLOGICAL:** PPP eye drops

## Key facts

- **NCT ID:** NCT02561520
- **Lead sponsor:** Ladan Espandar
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-12
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study did not enroll participants is being withdrawn from the system.
- **Last updated:** 2017-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561520, "Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02561520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*